Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Registry Study to Evaluate Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer

NCT05933733 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT05933733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05933733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Registry Study to Evaluate Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Recruiting
Start date
July 4, 2023
Completion date
July 31, 2033
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer